BMPR2 Therapy for Pulmonary Hypertension
BMPR2 Therapy for Pulmonary Hypertension
批准号:
nhmrc : 1010743
负责人:
Prof Paul Reynolds
金额:
$36.35万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2011
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2011-01-01 至 2014-12-31
中文摘要
肺动脉高压是一种影响肺部血管的疾病,会导致严重的呼吸短促和过早死亡。已知基因突变会导致这种疾病,但这些突变与肺部变化之间的确切联系尚不清楚。如果我们能更好地理解这个过程,我们就能设计出更好的治疗方法。这个项目将研究肺部细胞如何相互沟通,以及这个过程在肺动脉高压中是如何受到干扰的。
英文摘要
Pulmonary hypertension is a disease affecting the blood vessels in the lungs that causes severe shortness of breath and early death. Genetic mutations are known to cause this disease but the precise link between these mutations and the changes in the lungs are poorly understood. If we could understand this process better, we could design better treatments. This project will look at how the cells in the lungs communicate with each other and how this process is disturbed in pulmonary hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting the defective airway macrophage function in chronic obstructive pulmonary disease (COPD): a new therapeutic approach
-
批准号:nhmrc : 1106377
-
项目类别:Project Grants
-
资助金额:$48.81万
-
财政年份:2016
-
负责人:Prof Paul Reynolds
-
依托单位:
Targeting the defective airway macrophage function in chronic obstructive pulmonary disease (COPD): a new therapeutic approach
-
批准号:nhmrc : GNT1106377
-
项目类别:Project Grants
-
资助金额:$71.09万
-
财政年份:2016
-
负责人:Prof Paul Reynolds
-
依托单位:
Practitioner Fellowship
-
批准号:nhmrc : 1020516
-
项目类别:Practitioner Fellowships
-
资助金额:$30.65万
-
财政年份:2012
-
负责人:Prof Paul Reynolds
-
依托单位:
Practitioner Fellowship - Grant ID:453488
-
批准号:nhmrc : 453488
-
项目类别:NHMRC Research Fellowships
-
资助金额:$28.04万
-
财政年份:2007
-
负责人:Prof Paul Reynolds
-
依托单位:
Development of gene therapy strategies for pulmonary disease
-
批准号:nhmrc : 242812
-
项目类别:Career Development Fellowships
-
资助金额:$24.51万
-
财政年份:2003
-
负责人:Prof Paul Reynolds
-
依托单位:
The Role of Bone Morphogenetic Proteins in the Pathogenesis of Pulmonary Hypertension
-
批准号:nhmrc : 200504
-
项目类别:NHMRC Project Grants
-
资助金额:$15.77万
-
财政年份:2002
-
负责人:Prof Paul Reynolds
-
依托单位:
海外基金